The Kenneth S. Warren Institute is a not-for-profit organization based in Durham, North Carolina that as of 2017 appears to be defunct.
It had been based in Tarrytown, New York, and in 2001, the institute bought a 15-acre (61,000 m2) campus located in Westchester County, New York from the Kitchawan Institute. At that time its director and lead researcher was Anthony Cerami, and it was a medical research institute that had been doing research related to erythropoietin derivatives they called "tissue protective cytokines". They also said that they coordinated with researchers who were working on vaccines for neglected tropical diseases. Cerami has been president and trustee of an organization called the "Kenneth S. Warren Laboratories, Inc." as of March 1998.
The Kitchawan facility was for sale as of 2014.
In 2001, Warren Pharmaceuticals was formed to commercialize inventions made at the institute, starting with the cytokines, with funding from Lundbeck and a Danish bank; Cerami was chairman of the board. In 2001, the company licensed the cytokines to Lundbeck in the field of central and peripheral nervous system disorders. The development program was terminated in 2007.